About Puriti Labs
Qualitative Analysis by Lot #
Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug
Cannabidiol as a potential treatment for psychosis
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
Medical use of cannabis. Cannabidiol: A new light for schizophrenia?
A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation
Peripheral endocannabinoid system dysregulation in first-episode psychosis
Cannabinoids and schizophrenia: Therapeutic prospects
Antipsychotic-like effects of cannabidiol and rimonabant: Systematic review of animal and human studies
Cannabidiol monotherapy for treatment-resistant schizophrenia
Cannabis with high cannabidiol content is associated with fewer psychotic experiences
Marijuana compound treats schizophrenia with few side effects: Clinical trial
Clearing the smoke: what do we know about adolescent cannabis use and schizophrenia?